| Units | Total | Attack | Remission | Acute MY subgroup | Acute ON subgroup | Acute BRAIN subgroup |
---|---|---|---|---|---|---|---|
CSF white cell counts | |||||||
 Pleocytosis | Samples | 56/103 (54.4%) | 53/91 (58.2%) | 3/11 (27.3%) | 24/29 (82.8%) | 5/26 (19.2%) | 24/36 (66.7%) |
 WCC, all samples | Cells/μl | 11.5 (0–256; 102) | 14 (0–256; 91) | 4 (0–35; 11) | 41 (2–256; 29) | 2 (0–18; 25) | 22 (0–179; 36) |
 WCC, if elevated | Cells/μl | 40 (6–256; 56) | 42 (6–256; 53) | 23 (18–35; 3) | 70.5 (13–256; 24) | 10 (6–18; 5) | 44.5 (9–179; 24) |
 WCC, ≥ 100 | Samples | 11/103 (10.7%) | 11/91 (12.1%) | 0/11 (0%) | 9/29 (31%) | 0/26 (0%) | 2/36 (5.6%) |
 WCC, ≥ 100 | Cells/μl | 179 (103–256; 11) | 179 (103–256; 11) | n.a. (n.a.; 0) | 179 (103–256; 9) | n.a. (n.a; 0) | 176 (173–179; 2) |
 Lymphocytes | Samples | 45/45 (100%) | 43/43 (100%) | 2/2 (100%) | 20/20 (100%) | 11/11 (100%) | 12/12 (100%) |
 Monocytes | Samples | 35/45 (77.8%) | 34/43 (79.1%) | 1/2 (50%) | 15/20 (75%) | 7/11 (63.6%) | 12/12 (100%) |
 Neutrophils | Samples | 32/45 (71.1%) | 31/43 (72.1%) | 1/2 (50%) | 15/20 (75%) | 5/11 (45.5%) | 11/12 (91.7%) |
 Eosinophils | Samples | 3/45 (6.7%) | 3/43 (7%) | 0/2 (0%) | 2/20 (10%) | 0/11 (0%) | 1/12 (8.3%) |
 Basophils | Samples | 2/45 (4.4%) | 2/43 (4.7%) | 0/2 (0%) | 1/20 (5%) | 1/11 (9.1%) | 0/12 (0%) |
 Plasma cells | Samples | 2/45 (4.4%) | 2/43 (4.7%) | 0/2 (0%) | 1/20 (5%) | 0/11 (0%) | 1/12 (8.3%) |
 Lymphoid cells | Samples | 3/45 (6.7%) | 3/43 (7%) | 0/2 (0%) | 2/20 (10%) | 1/11 (9.1%) | 0/12 (0%) |
 Macrophages | Samples | 3/45 (6.7%) | 3/43 (7%) | 0/2 (0%) | 1/20 (5%) | 2/11 (18.2%) | 0/12 (0%) |
 No pleocytosis | Samples | 47/103 (45.6%) | 38/91 (41.8%) | 8/11 (72.7%) | 5/29 (17.2%) | 21/26 (80.8%) | 12/36 (33.3%) |